Hebcal New York Loading…
  • Home  
  • PFIZER only 42% effective against infection in July, Study
- Coronavirus

PFIZER only 42% effective against infection in July, Study

|
Anjel Newmann, 32, kneels while scanning her phone during a peaceful rally in Providence, R.I. on Friday, June 5. Newmann said she’s mostly using Instagram and Facebook to organize protests while people younger than her are using Snapchat. (AP Photo/Matt O'Brien)|Anjel Newmann, 32, kneels while scanning her phone during a peaceful rally in Providence, R.I. on Friday, June 5. Newmann said she’s mostly using Instagram and Facebook to organize protests while people younger than her are using Snapchat. (AP Photo/Matt O'Brien)
Getting your Trinity Audio player ready...

A new preprint study(LINK) that raises concerns about the mRNA vaccines’ effectiveness against Delta — particularly Pfizer’s COVID vaccine, Axios reported.

The study found the Pfizer vaccine was only 42% effective against infection in July, when the Delta variant was dominant. This runs contrary to endless media reports that most new COVID cases are from the unvaccinated.

Axios summarized:

The study, conducted by nference and the Mayo Clinic, compared the effectiveness of the Pfizer and Moderna vaccines in the Mayo Clinic Health System over time from January to July.

  • Overall, it found that the Moderna vaccine was 86% effective against infection over the study period, and Pfizer’s was 76%. Moderna’s vaccine was 92% effective against hospitalization and Pfizer’s was 85%.
  • But the vaccines’ effectiveness against infection dropped sharply in July, when the Delta variant’s prevalence in Minnesota had risen to over 70%.
  • Moderna was 76% effective against infection, and Pfizer was only 42% effective.
  • The study found similar results in other states. For example, in Florida, the risk of infection in July for people fully vaccinated with Moderna was about 60% lower than for people fully vaccinated with Pfizer.

Although it has yet to be peer-reviewed, the study raises serious questions about both vaccines’ long-term effectiveness, particularly Pfizer’s- Axios reported.

Leave a comment

Your email address will not be published. Required fields are marked *